Participation in warrant exercise by Curasight management
December 10, 2024
Regulatory
Copenhagen, Denmark, 10 December 2024 - Curasight A/S ("Curasight" or the “Company" - TICKER: CURAS) hereby announces in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, the disclosure of participation by members of Curasight’s Board of Directors and Executive Management team in the warrant exercise conducted on December 5[th] 2024.
The following is an overview of the transactions relating to the T02 warrants:
| Name | Position | Aggregated volume | Price, DKK |
| Kirsten Drejer | Chair of the Board | 12,174 | 140,001.00 |
| Lars Trolle | Deputy chair of the Board | 5,000 | 57,500.00 |
| Charlotte Vedel Johansen | Board member | 8,695 | 99,992.50 |
| Ulrich Krasilnikoff | CEO & CFO, Board member | 43,479 | 500,008.50 |
| Andreas Kjær | CMO & CSO, Board member | 43,479 | 500,008.50 |
| Total | 112,827 | 1,297,510.50 |
For further information regarding Curasight, please contact:
Ulrich Krasilnikoff, CEO
Phone: +45 22 83 01 60
E-mail: uk@curasight.com
www.curasight.com